• DRAMP ID

    • DRAMP36084
    • Sequence

    • INLEACLGRTLMD
    • Sequence Length

    • 13
    • Sequence Name

    • Source

    • Synthetic
    • SMILES

    • CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@@H](C)O
    • Activity

    • Antimicrobial, Anticancer
    • Patent Type

    • Patent Application
    • Publication Date

    • 2000-5-2
    • Patent Title

    • Antiangiogenic peptides polynucleotides encoding same and methods for inhibiting angiogenesis
    • Abstract

    • Mammalian kringle 5 fragments and kringle 5 fusion proteins are disclosed as a compounds for treating angiogenic diseases. Methods and compositions for inhibiting angiogenic diseases are also disclosed.